These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 7734324
1. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G, Dervan PA. Br J Cancer; 1995 May; 71(5):981-5. PubMed ID: 7734324 [Abstract] [Full Text] [Related]
7. The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target. Picksley SM, Spicer JF, Barnes DM, Lane DP. Acta Oncol; 1996 Jan; 35(4):429-34. PubMed ID: 8695156 [Abstract] [Full Text] [Related]
8. [Study of mdm2 gene amplification in primary breast tumors]. Fontana X, Ferrari P, Abbes M, Monticelli J, Namer M, Bussière F. Bull Cancer; 1994 Jul; 81(7):587-92. PubMed ID: 7742600 [Abstract] [Full Text] [Related]
10. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation. Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T, Ishiguro S, Takami K, Nakayama T, Nishisho I. Br J Cancer; 1997 Jul; 75(9):1302-8. PubMed ID: 9155050 [Abstract] [Full Text] [Related]
11. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. Günther T, Schneider-Stock R, Rys J, Niezabitowski A, Roessner A. J Cancer Res Clin Oncol; 1997 Jul; 123(7):388-94. PubMed ID: 9260591 [Abstract] [Full Text] [Related]
12. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF. Cancer Res; 2001 Apr 01; 61(7):3212-9. PubMed ID: 11306511 [Abstract] [Full Text] [Related]
13. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, Theillet C. Br J Cancer; 1996 Dec 01; 74(12):1984-9. PubMed ID: 8980401 [Abstract] [Full Text] [Related]
18. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Tarapore P, Fukasawa K. Oncogene; 1999 Mar 18; 18(11):1935-44. PubMed ID: 10208415 [Abstract] [Full Text] [Related]
19. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708 [Abstract] [Full Text] [Related]
20. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation. Pruneri G, Pignataro L, Carboni N, Luminari S, Capaccio P, Neri A, Buffa R. Mod Pathol; 1997 Aug 15; 10(8):785-92. PubMed ID: 9267820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]